KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Sep 2025 value amounting to $17.9 million.

  • Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 1.95% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 1.95%. This contributed to the annual value of $17.6 million for FY2024, which is 1.02% up from last year.
  • Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $17.9 million in Q3 2025, which was up 0.36% from $17.9 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $17.9 million in Q3 2025 and a low of $17.0 million during Q1 2021.
  • Over the past 3 years, Rigel Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $17.5 million (recorded in 2024), while the average stood at $17.6 million.
  • Data for Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY rose of 1.95% (in 2025) over the last 5 years.
  • Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarterly) stood at $17.1 million in 2021, then climbed by 1.07% to $17.3 million in 2022, then climbed by 0.89% to $17.4 million in 2023, then climbed by 1.02% to $17.6 million in 2024, then increased by 1.95% to $17.9 million in 2025.
  • Its last three reported values are $17.9 million in Q3 2025, $17.9 million for Q2 2025, and $17.9 million during Q1 2025.